Maintaining Drug Product Properties and Optimizing Late-Stage Manufacturing Efficiency
Summary: Maintaining drug product properties established during the development stage while optimizing late-stage manufacturing efficiency of oral solid dosage forms is a balancing act during scale-up and tech transfer. Implementing modelling tools and Quality by Design (QbD) approaches early in development can help minimize the burdens often faced in the transition from early phase to late phase of a small
molecule program.
In this webinar, experts provide an overview of the latest trends in manufacturing of oral solid dosage form and discuss key considerations of transitioning an early-stage project to late-stage as well as technology transfer. The experts also demonstrate how multivariate modeling tools can help scientists understand the relationship between critical material attributes and critical process parameters, and how they impact the finished dosage form in large scale production.